Concepedia

Publication | Open Access

Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China

DOIFull Paper Access

195

Citations

34

References

2017

Year

Nan Chen, Jiaqi Qian, Jianghua Chen, Xueqing Yu, Changlin Mei, Chuan‐Ming Hao, Gengru Jiang, Hongli Lin, Xinzhou Zhang, Li Zuo,
Nephrology Dialysis Transplantation

Abstract

FG-4592 may prove an effective alternative for managing anemia of CKD. It is currently being investigated in a pivotal global Phase 3 program.

References

YearCitations

Page 1